Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Zebra Technologies logoZebra Technologies ZBRA

The company said its Board increased the size of the Board from 10 to 11 directors and increased the number of Class I directors from 3 to 4 on July 25, 2025, and appointed Mary McDowell as a Class I director.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said its Board increased the size of the Board from 10 to 11 directors and increased the number of Class I directors from 3 to 4 on July 25, 2025, and appointed Mary McDowell as a Class I director.

  2. Zebra said it increased the size of the Audit Committee from 5 to 6 members and appointed McDowell as a member. The term of Class I directors expires at the 2027 Annual Meeting of Stockholders, and McDowell will stand for election at that meeting.

  3. The company said McDowell's compensation will follow its standard compensation arrangements for non-employee directors and will be prorated to her Board start date. It also said it and McDowell will enter into an indemnification agreement. The company said there were no arrangements or understandings under which McDowell was appointed as a director, and no related party transactions requiring disclosure under Item 404(a).

  4. The company said its press release described McDowell as the former President, CEO and Board director of Mitel Networks and former CEO and Board director of Polycom. It said she led a global feature phone business with $15B in revenue at Nokia, and is currently Board Chair of Informa TechTarget and a director of Arrow Electronics.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Mary McDowell Joins Zebra Board; Board Size Expanded

The company said its Board increased the size of the Board from 10 to 11 directors and increased the number of Class I directors from 3 to 4 on July 25, 2025, and appointed Mary McDowell as a Class I director.

Source · Based on the filing body and exhibits

Audit Committee Expanded; Class I Term Details

Zebra said it increased the size of the Audit Committee from 5 to 6 members and appointed McDowell as a member. The term of Class I directors expires at the 2027 Annual Meeting of Stockholders, and McDowell will stand for election at that meeting.

Source · Based on the filing body and exhibits

Director Pay and Indemnification; No Related Party Transactions

The company said McDowell's compensation will follow its standard compensation arrangements for non-employee directors and will be prorated to her Board start date. It also said it and McDowell will enter into an indemnification agreement. The company said there were no arrangements or understandings under which McDowell was appointed as a director, and no related party transactions requiring disclosure under Item 404(a).

Source · Based on the filing body and exhibits

McDowell's Career Background

The company said its press release described McDowell as the former President, CEO and Board director of Mitel Networks and former CEO and Board director of Polycom. It said she led a global feature phone business with $15B in revenue at Nokia, and is currently Board Chair of Informa TechTarget and a director of Arrow Electronics.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.